Modality Solutions Reports 2019 Strongest Year Ever Driven by Awards & Certification

Modality Solutions Reports 2019 Strongest Year Ever Driven by Awards & Certification

Written by Modality Solutions

Posted on: January 22, 2020

We are pleased to announce our 2019 milestone highlights include recognition by both Inc. 5000 and the Houston Business Journal as a fastest growing company. We also achieved ISO 9001:2015 certification–with the scope of the accreditation covering consulting, design and engineering services and testing for supply chain logistics related to transport-sensitive drug products. Also, we received the distinction of being one of the “Best Entrepreneurial Companies in America” by Entrepreneur magazine on its 2019 Entrepreneur 360™ List.

Our Co-founder and President, Gary Hutchinson, was accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives. Gary was vetted and selected by a review committee based on the depth and diversity of his experience. 

The biopharmaceutical industry also benefited from our first live webinar on September 19. Principals Dan Littlefield and Gary covered a step-by-step cold chain validation process to help pharmaceutical companies meet and exceed increasingly stringent regulatory expectations, including monoclonal antibodies, antibody-drug conjugates, and cell therapies. And, we were a Silver Sponsor and cold chain validation workshop presenter at the Biomanufacturing World Summit (BMWS19) Conference in San Diego from November 11-12.

“2019 was a stellar year for us, with ISO 9001:2015 certification, recognition by Inc. and Entrepreneur magazines, participation in the Forbes Tech Council, and continuing to partner with our clients to validate safe, and effective cold chains,” said Gary. “As we continue our mission into the next decade, our vision for the future is to continue to expand with our team of experienced engineers our ongoing role to promote safe, effective and validated cold chain for a whole range of therapies.” 

To view the complete online press release, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *